Merck Global Health Innovation Fund, Microsoft Ventures, Zaffre Investments and Echo Health Ventures invested in a round that valued Livongo at $800m.
Livongo Health, the US-based developer of an assistance platform for chronic health conditions, secured $105m yesterday that included software provider Microsoft, pharmaceutical firm Merck and health insurer Blue Cross Blue Shield of Massachusetts.
General Catalyst and Kinnevik co-led the round, which included DFJ, Kleiner Perkins Caufield & Byers (KPCB), Sapphire Ventures, 7wire Ventures and Echo Health Ventures, the fund formed by care provider Cambia Health and Blue Cross and Blue Shield of North Carolina.
The round valued Livongo at $800m…